XML 187 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Consolidated Cash Flows (Unaudited) - CERC - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities:    
Net Income $ 771 $ 725
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,083 1,042
Deferred income taxes 238 94
Changes in other assets and liabilities:    
Accounts receivable and unbilled revenues, net 145 528
Inventory 19 63
Taxes receivable (75) (47)
Accounts payable (247) (443)
Current regulatory assets and liabilities (91) 1,173
Non-current regulatory assets and liabilities (553) (71)
Other current assets and liabilities (25) (41)
Other non-current assets and liabilities 31 59
Other operating activities, net (37) 9
Net cash provided by operating activities 1,250 3,069
Cash Flows from Investing Activities:    
Capital expenditures (2,501) (3,323)
Other investing activities, net (58) (12)
Net cash used in investing activities (2,559) (3,190)
Cash Flows from Financing Activities:    
Decrease in short-term borrowings, net (2) (14)
Payments of commercial paper, net (520) (1,496)
Proceeds from long-term debt and term loans, net 2,757 5,574
Payments of long-term debt and term loan (963) (2,613)
Payment of debt issuance costs (25) (50)
Other financing activities, net (28) (25)
Net cash provided by (used in) financing activities 1,329 168
Net Increase in Cash, Cash Equivalents and Restricted Cash 20 47
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 109 91
Cash, Cash Equivalents and Restricted Cash at End of Period 129 138
CERC    
Cash Flows from Operating Activities:    
Net Income 345 283
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 389 365
Deferred income taxes 95 (113)
Changes in other assets and liabilities:    
Accounts receivable and unbilled revenues, net 333 724
Accounts receivable/payable–affiliated companies (1) 57
Inventory (9) 90
Taxes receivable (5) 0
Accounts payable (124) (384)
Current regulatory assets and liabilities (89) 1,129
Non-current regulatory assets and liabilities (20) 63
Other current assets and liabilities (41) 64
Other non-current assets and liabilities 18 (5)
Other operating activities, net (33) (3)
Net cash provided by operating activities 858 2,270
Cash Flows from Investing Activities:    
Capital expenditures (1,027) (1,219)
Decrease (increase) in notes receivable–affiliated companies 1 (86)
Other investing activities, net 44 (15)
Net cash used in investing activities (982) (1,320)
Cash Flows from Financing Activities:    
Decrease in short-term borrowings, net (2) (14)
Payments of commercial paper, net (287) (805)
Proceeds from long-term debt and term loans, net 399 2,006
Payments of long-term debt and term loan 0 (2,275)
Dividends to parent (270) (347)
Payment of debt issuance costs (4) (13)
Contribution from parent 290 500
Other financing activities, net (2) (1)
Net cash provided by (used in) financing activities 124 (949)
Net Increase in Cash, Cash Equivalents and Restricted Cash 0 1
Cash, Cash Equivalents and Restricted Cash at Beginning of Period 1 0
Cash, Cash Equivalents and Restricted Cash at End of Period $ 1 $ 1